Our formulation development team comprises of eminent scientists engaged in dedicated and focused research towards developing oncology/non-oncology finished dosage forms. We have good experience in formulation development of solid orals & parenterals (Lyophilized products/liquid injectables). We have been designing effective strategies for formulation development, targeting minimization of regulatory risk queries and providing affordable products with patient compliance. As per our long term plan now we are also focusing on New Drug Delivery systems (NDDS) and biotech products like small peptides. We have a track record of trouble-free technology transfer, scale-up, optimization, exhibit batch trials, and we are equipped with suitable experience and decision-making strengths in bioequivalence/permeability studies. We make sure that our complete process development is fully compliant with QbD concepts and the cGMP requirements.
Journey from innovative ideas to successful commercialisation through comprehensive product development
In our quest for incremental innovation to add value or meet unmet medical need, we would continuously look for opportunities to change or improve the existing drug products and delivery systems. Our competency and strong knowledge base in the area of dosage design would be of great help to Speciality Companies looking for customized delivery systems
Exploring alternate routes, product enhancement, modified release dosage forms design exploration product life cycle planning, line extensions and technology development are our Strategic Key Focus Areas.